The primary value of placebo controls in clinical trials is the minimization of bias.

Only 1 in 10 nonsurgical treatments for low back pain are more effective placebo, a review of 56 different treatments and ...

Discover recent clinical trial failures in depression and explore potential pathways for advancing antidepressant drug ...

Novo Nordisk on Monday announced a $2 billion deal with a Chinese company making a drug in the same GLP-1 space where the ...

The Food and Drug Administration (FDA) recently approved a new, non-opioid (non-narcotic) prescription pill, suzetrigine (SUE ...

There was no difference between the effect sizes of discontinued drugs compared with currently marketed NSAIDs (MD 0.3, 95% CI −3.7 to 4.3; p=0.88), although no trials investigating celecoxib were ...

Novo Nordisk's hopes of heralding a new era of obesity treatment with its next-generation CagriSema drug may be in doubt ...

The FDA approves a new non-opioid pain pill, Journavx, to treat acute pain in adults. It's a first-generation non-addictive ...

Since 2016, the FDA has approved three disease-modifying treatments for spinal muscular atrophy, with several ...

Paracetamol is one of the most widely used painkillers in the world. It is often recommended as a safer alternative to ...

For the first time, scientists say, they have evidence that using a biologic drug to remove sticky beta amyloid plaques from ...